China Traditional Chinese Medicine Holdings Co. Limited (0570.HK)
- Previous Close
4.230 - Open
4.230 - Bid 4.210 x --
- Ask 4.220 x --
- Day's Range
4.210 - 4.240 - 52 Week Range
2.800 - 4.380 - Volume
16,518,438 - Avg. Volume
24,651,912 - Market Cap (intraday)
21.251B - Beta (5Y Monthly) 0.52
- PE Ratio (TTM)
15.07 - EPS (TTM)
0.280 - Earnings Date Mar 21, 2024
- Forward Dividend & Yield 0.05 (1.23%)
- Ex-Dividend Date Jun 2, 2023
- 1y Target Est
4.62
China Traditional Chinese Medicine Holdings Co. Limited, an investment holding company, engages in the research and development, production, and sale of traditional Chinese medicine (TCM) and pharmaceutical products in the People's Republic of China. It operates through four segments: Yi Fang, Tian Jiang, Tong Ji Tang, and Medi-World. The company manufactures, manages, and sells concentrated TCM granules, and TCM health care products and decoction pieces under the Yi Fang, Tian Jiang, and Tong Ji Tang brand names; and offers Chinese medical related healthcare solutions including Chinese medical consultation and diagnosis, TCM physiotherapy, and prescription with concentrated TCM granules through offline medical institutions. It also provides manufacture and sale of TCM finished drugs under various brands, such as Medi-world, De Zhong, and Feng Liao Xing brands. In addition, the company engages in the sale of medical herbs; trading of pharmaceutical products; leasing of properties; and provision of TCM marketing, advertising, and consulting services. It sells its products to hospitals and retail pharmacies. The company was formerly known as China Traditional Chinese Medicine Co. Limited and changed its name to China Traditional Chinese Medicine Holdings Co. Limited in 2016. China Traditional China Traditional Chinese Medicine Holdings Co. Limited was founded in 1573 and is based in Wan Chai, Hong Kong.
www.china-tcm.com.cn17,303
Full Time Employees
December 31
Fiscal Year Ends
Sector
Recent News: 0570.HK
Performance Overview: 0570.HK
Trailing total returns as of 5/31/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 0570.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 0570.HK
Valuation Measures
Market Cap
21.25B
Enterprise Value
22.63B
Trailing P/E
15.07
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.07
Price/Book (mrq)
0.92
Enterprise Value/Revenue
1.14
Enterprise Value/EBITDA
8.07
Financial Highlights
Profitability and Income Statement
Profit Margin
7.09%
Return on Assets (ttm)
2.32%
Return on Equity (ttm)
5.95%
Revenue (ttm)
18.12B
Net Income Avi to Common (ttm)
1.29B
Diluted EPS (ttm)
0.280
Balance Sheet and Cash Flow
Total Cash (mrq)
3.69B
Total Debt/Equity (mrq)
21.56%
Levered Free Cash Flow (ttm)
536.42M